Technology Offerings

The ozone-based innovation allows to arrest progression of the tumor and to induce tumor regression up to a complete remission. The innovation comprises the utilization of a novel device for the application of an ozone- or ozonized oxygen-containing fluid in a human or animal torso or, more precisely, for intraperitoneal application, whereby application does not need to take place in immediate contact with the tumor in order to be effective.

Treatment with high energy radiation is a generally recognized method in cancer therapy. Instead of high energy radiation, particle therapy uses accelerated charged particles, such as protons or heavy ions (e.g. carbon). The difference between particle therapies in comparison to conventional radiotherapy is the deviant penetration behavior of the particles.The novel system provides the unique possibility of combined diagnosis and therapy by means of ion beams.

Red mites are the most common ectoparasites of poultry and cause substantial economic damage worldwide. Scientists at the University of Hohenheim have developed a method to combat red mites which utilizes the fact that the mites are sensitive to heat and that the parasite only visits the host at night for feeding and then hides in dark spaces near the host. The method presents hollow, perforated perches as appropriate hiding places where mites in all states of development are killed through thermal treatment. Because of the purely mechanical nature of the process there is no health risk for personnel. Since temperature and speed of the heating device are regulated by a PLC (programmable logic controller), farm workers are free to carry out other tasks while the treatment takes place.

The invention presented here is a temperature-compensated FBG measurement system based on interferometry. It is characterized by naturally high sensitivity and high dynamic range well in excess of a period of interference. The system makes do with commercially available and cheap components that can be easily combined and implemented.

The inventors here present a novel, highly specialized plasma membrane protein responsible for citrate uptake in cancer cells. This transporter with its function of citrate import is a specific marker for cancer cells and offers therefore a promising target for diagnostic and therapeutic approaches.

The invention provides small molecular compounds as potential drugs against trypanosome infection diseases including African trypanosomiasis (human “sleeping sickness” and cattle “Nagana pest”), Chagas disease and Leishmaniasis.